Mary Vaughan Sarrazin
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Dosing of Direct Oral Anticoagulants for stroke prevention in Atrial Fibrillation: Patterns, Consequences, and Guidance
Open Date: 2017-09-15
Close Date: 2020-04-30
Grant: Close
Stroke Prevention for Atrial Fibrillation with Multiple Chronic Conditions
Open Date: 2014-09-01
Close Date: 2017-02-28
Grant: Close
Comparative effectiveness of dabigatran and warfarin for stroke prevention in atr
Open Date: 2012-09-06
Close Date: 2014-08-31
Grant: Close
Impact of Certificate of Need on the Use of Revascularization for AMI
Open Date: 2006-06-01
Close Date: 2008-05-31
Grant: Close
The significance of racial segregation for CV disease
Open Date: 2006-03-01
Close Date: 2009-02-28
Articles (10)
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Objective Rural veterans have high obesity rates. Yet, little is known about this population's engagement with the Veterans Affairs (VA) weight management program (MOVE!). The study objective is to determine whether MOVE! enrollment, anti‐obesity medication use, bariatric surgery use, retention, and outcomes differ by rurality for veterans with severe obesity. Methods This is a retrospective cohort study using Veterans Health Administration patient databases, including VA patients with severe obesity during 2015–2017. Patients were categorized using Rural‐Urban Commuting Area codes. Primary outcomes included proportion of patients and risk‐adjusted likelihood of initiating VA MOVE!, anti‐obesity medication, or bariatric surgery and risk‐adjusted highly rural|Hazard Ratio (HR) of any obesity treatment. Secondary outcomes included treatment retention (≥12 weeks) and successful weight loss (5%) among patients initiating MOVE!, and risk‐adjusted odds of retention and successful weight loss. Results Among 640,555 eligible veterans, risk‐adjusted relative likelihood of MOVE! treatment was significantly lower for rural and HR veterans (HR = 0.83, HR = 0.67, respectively). Initiation rates of anti‐obesity medication use were significantly lower as well, whereas bariatric surgery rates, retention, and successful weight loss did not differ. Conclusions Overall treatment rates with MOVE!, bariatric surgery, and anti‐obesity medications remain low. Rural veterans are less likely to enroll in MOVE! and less likely to receive anti‐obesity medications than urban veterans.
Year:
2022
Collaborators (13)
Neil Keshvani
University of Texas Southwestern Medical Center
Benjamin Griffin
Assistant Professor
Iowa State University
Marwan Saad
Brown University Warren Alpert Medical School
Dharam J. Kumbhani
-
Shipra Arya
Stanford University School of Medicine
Daniel Livorsi
The University of Iowa Roy J and Lucille A Carver College of Medicine
Saket Girotra
Associate Professor
University of Texas Southwestern Medical Center
Rolando Sanchez
Associate professor, clinician educator track
Iowa State University
Michael Matheny
Associate Professor
Vanderbilt University Medical Center
Sharidan Parr
Vanderbilt University Medical Center
Olga V Patterson
University of Utah
Nihar R. Desai
-
Michihiko Goto
Associate Professor
The University of Iowa Roy J and Lucille A Carver College of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.